Health
Clover Biopharma’s new trimeric subunit vaccine candidate prevents COVID-19 in monkeys – News-Medical.Net
The vaccine candidate produced a high level of neutralizing antibodies in animal models. Rhesus macaques immunized with the vaccine candidate showed reduced viral loads in the lungs. The research is published on the preprint server bioRxiv.
Researchers from Clover Biopharmaceuticals, the Chinese Academy of Sciences, and China’s National Institutes for Food and Drug Control (NIFDC) report a trimeric subunit vaccine candidate similar to the spike protein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The vaccine candidate produced a high level of neutralizing antibodies in animal models. Rhesus macaques immunized with the vaccine candidate showed reduced viral loads in the lungs. The research is published on the…
-
General10 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General13 hours agoAlbanese beats drum on economy as trade clouds gather
-
Business9 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
Noosa News12 hours agoSurgeon partner of former premier to testify over his patient’s death